Title:
線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法
Document Type and Number:
Japanese Patent JP6618066
Kind Code:
B2
Abstract:
The present invention aims to provide a method which has not been established yet and which is useful for achieving long-term and fundamental cure of a necrotic cardiac tissue region to allow recovery of functionality of the heart. The present invention provides an injectable composition for treatment of a cardiac disease, the composition comprising fibroblasts, wherein the fibroblasts contain CD106-positive fibroblasts, preferably contain CD90-positive fibroblasts.
Inventors:
Takahiro Iwamiya
Application Number:
JP2019501845A
Publication Date:
December 11, 2019
Filing Date:
February 23, 2018
Export Citation:
Assignee:
Methusela Co., Ltd.
International Classes:
A61K35/33; A61K9/08; A61P9/00; A61P9/04; A61P9/10; C12N5/071
Domestic Patent References:
| JP2016027797A | ||||
| JP2016519938A |
Foreign References:
| US20060057124 |
Other References:
South China Journal of Cardiology, 2011, Vol.12, No.2, pp.112-117
Biomaterials (2011) Vol.32, No.30, pp.7355-7362
Biomaterials (2011) Vol.32, No.30, pp.7355-7362
Attorney, Agent or Firm:
Hidewa Patent Office